Baird Medical Investment

BDMD

----

Current ValuationThe current P/E ratio is -0.30, above the reasonable range, cheaper than 8.43% of the time in the past 1 years, and the industry ranks 66/173, the industry Median -0.74.

-0.297xP/E

Stock price$0.11Earnings per share$-0.38

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

014284256

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GKOSUSGlaukos	-82.93x	90.98%	$14.08B
BAXUSBaxter	-18.90x	166.27%	$13.66B
PLSEUSPulse Biosciences	-51.10x	21.30%	$4.28B
AXGNUSAxogen	-93.07x	12.42%	$2.97B
IRTCUSIRhythm	-75.80x	15.49%	$2.92B
ASSTUSStrive	-9.06x	57.99%	$2.66B
BFLYUSButterfly Network	-33.23x	36.13%	$1.78B
KMTSUSKestra Medical Tech	-11.78x	0.79%	$1.77B
ENOVUSEnovis	-3.12x	99.13%	$1.65B
NVCRUSNovocure	-12.03x	13.66%	$1.46B
DRTSUSAlpha Tau Medical	-14.07x	--	$1.30B
PRCTUSPROCEPT BioRobotics	-11.21x	0.07%	$1.29B
TNDMUSTandem Diabetes	-25.76x	77.37%	$1.27B
SIBNUSSI-BONE	-84.39x	21.94%	$1.15B
ATECUSAlphatec	-13.18x	51.67%	$1.14B
CBLLUSCeribell	-14.51x	39.46%	$1.07B
AORTUSArtivion	-57.10x	326.99%	$1.01B
BBNXUSBeta Bionics	-11.09x	13.23%	$921.52M
QDELUSQuidelOrtho	-2.25x	72.55%	$829.53M
SGHTUSSight Sciences	-21.55x	26.25%	$611.92M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.